Animalcare Group plc (AIM:ANCR)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 173.16M |
| Revenue (ttm) | 81.07M |
| Net Income (ttm) | 2.98M |
| Shares Out | 68.99M |
| EPS (ttm) | 0.05 |
| PE Ratio | 55.61 |
| Forward PE | 17.51 |
| Dividend | 0.05 (2.07%) |
| Ex-Dividend Date | Oct 16, 2025 |
| Volume | 32,534 |
| Average Volume | 1,087,885 |
| Open | 251.30 |
| Previous Close | 251.00 |
| Day's Range | 250.13 - 252.00 |
| 52-Week Range | 202.00 - 305.35 |
| Beta | 0.38 |
| RSI | 57.93 |
| Earnings Date | Dec 24, 2025 |
About Animalcare Group
Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company has a collaboration with 272Bio Limited to develop and commercialize a novel biological treatment for a common equine skin condition, known as sweet itch. The company operates in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, Asia, the Middle East, Africa, European Union, and internationally. Animalcare Group plc is based in York, ... [Read more]
Financial Performance
In 2024, Animalcare Group's revenue was 74.23 million, an increase of 4.94% compared to the previous year's 70.73 million. Earnings were 18.49 million, an increase of 1442.45%.
Financial StatementsNews
Animalcare sees revenue growth and improved cash position
Animalcare has a transformational year as disposal of Identicare and STEM sees cash position swell to GBP32.9m